In regards to the CRC subtypes, Wang et al., found that the expression of Beclin 1 and LC3 was unrelated to all clinicopathological parameters and overall survival in the MSI-H-CRC subgroup (67). This evidence concerns the gene MAP1LC3A and colorectal carcinoma.